The Application of rhG-CSF,Cord Blood and Auto-peripheral Blood Stem Cells for Chemotherapy Induced Agranulocytosis

李惠平,贾廷珍,马力文,邓惠静,张淑兰
DOI: https://doi.org/10.3969/j.issn.1004-0242.2004.02.022
2004-01-01
Abstract:To investigate the role of rhG-CSF,cord blood and auto-peripheral blood stem cells in treatment of chemotherapy induced agranulocytosis.The comprehensive therapy were applied for 22 cancer patients with chemotherapy whose absolute neutrophil count (ANC)was below 0.5×109/L;45 patients with cancer were randomized in to three groups received rhG-CSF,cord blood and auto-peripheral blood stem cell respectively.The change of ANC was observed with self-case control.WBC and ANC in 22 patients with agranulocytosis reached to the lowest value at (12.24±2.08) days after chemotherapy. ANC in 17 patients were lower than 0.5×109/L,5 were lower than 0.1×109/L.No infection presented following the treatment of rhG-CSF and cord blood. After prophylactic treatment with rhG-CSF, cord blood and auto-peripheral blood stem cells,the bone marrow depression was notably slighter than that of control cycle and recovery period was shorter.[Conclusion]Adoption of rhG-CSF ,cord blood and auto-peripheral blood stem cells will benefit the recovery of hemogenesis of the bone marrow.
What problem does this paper attempt to address?